Faeth Therapeutics, Inc. (FTH) vs Puma Biotechnology, Inc. (PBYI)
- Faeth Therapeutics, Inc. FTH 18.79 −8.79%
- Puma Biotechnology, Inc. PBYI 9.83 −6.56%
Faeth Therapeutics, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Faeth Therapeutics, Inc. and Puma Biotechnology, Inc. are of similar size ($543.0M and $532.3M). Faeth Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 14 metrics below, Puma Biotechnology, Inc. leads on 10 and Faeth Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | FTH | PBYI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 74.83% | 65.16% |
| Operating margin | 0.00% | 13.16% | 0.00% |
| Net margin | 0.00% | 11.55% | 0.00% |
| Free cash flow margin | 0.00% | 17.79% | 0.00% |
| Return on equity | (195.26%) | 21.97% | (56.36%) |
| Return on assets | (176.88%) | 13.78% | (48.04%) |
| Return on invested capital | 0.00% | 42.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack